Adipokines and the immune system: An adipocentric view

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 1-21

  MacLaren, Robin ^a,b   Cui, Wei ^a,b   Cianflone, Katherine ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPOCYTOKINE; ADIPONECTIN; APELIN; COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5 LIGAND 2; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPCIDIN; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOPONTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; CHEMOKINE RECEPTOR; COMPLEMENT C3A, DES ARG (77); COMPLEMENT C3A, DES-ARG-(77); CYTOKINE; GPR77 PROTEIN, MOUSE;

CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; FAT BODY; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; LIGAND BINDING; LIPID METABOLISM; LIPOGENESIS; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; WEIGHT REDUCTION; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM; MOUSE;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; COMPLEMENT C3A; CYTOKINES; HUMANS; IMMUNE SYSTEM; LIPID METABOLISM; MICE; MODELS, BIOLOGICAL; RECEPTORS, CHEMOKINE;

EID: 58149347247     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_1     Document Type: Review

References (94)

1. Arora, K.K., Cheng, Z. and Catt, K.J. (1997) Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol. Endocrinol. 11, 1203-1212
2. Baldo, A., Sniderman, A.D., St Luce, S., Avramoglu, R.K., Maslowska, M., Hoang, B., Monge, J.C., Bell, A., Mulay, S. and Cianflone, K. (1993) The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Invest. 92, 1543-1547
3. Barrington, R., Zhang, M., Fischer, M. and Carroll, M.C. (2001) The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180, 5-15
4. Beltowski, J. (2006) Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity? Med. Sci. Monit. 12, RA112-RA119
5. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. and Scherer, P.E. (2001) The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953
6. Bouloumie, A., Curat, C.A., Sengenes, C., Lolmede, K., Miranville, A. and Busse, R. (2005) Role of macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab Care. 8, 347-354
7. Cain, S.A. and Monk, P.N. (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277, 7165-7169
8. Cancello, R. and Clement, K. (2006) Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 113, 1141-1147
9. Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.L., Bouloumie, A., Barbatelli, G., Cinti, S., Svensson, P.A., Barsh, G.S., Zucker, J.D., Basdevant, A., Langin, D. and Clement, K. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277-2286
10. Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J.L., Hugol, D., Coussieu, C., Basdevant, A., Bar, H.A., Bedossa, P., Guerre-Millo, M. and Clement, K. (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55, 1554-1561
11. Chen, A., Gao, Z.G., Barak, D., Liang, B.T. and Jacobson, K.A. (2001) Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis. Biochem. Biophys. Res. Commun. 284, 596-601
12. Chen, N.J., Mirtsos, C., Suh, D., Lu, Y.C., Lin, W.J., McKerlie, C., Lee, T., Baribault, H., Tian, H. and Yeh, W.C. (2007) C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446, 203-207
13. Choy, L.N. and Spiegelman, B.M. (1996) Regulation of alternative pathway activation and C3a production by adipose cells. Obes. Res. 4, 521-532
14. Choy, L.N., Rosen, B.S. and Spiegelman, B.M. (1992) Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267, 12736-12741
15. Chung, D.A., Wade, S.M., Fowler, C.B., Woods, D.D., Abada, P.B., Mosberg, H.I. and Neubig, R.R. (2002) Mutagenesis and peptide analysis of the DRY motif in the alpha2A adrenergic receptor: evidence for alternate mechanisms in G protein-coupled receptors. Biochem. Biophys. Res. Commun. 293, 1233-1241 Chung, S., Lapoint, K., Martinez, K., Kennedy, A., Boysen, S.M. and McIntosh, M.K. (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147, 5340-5351
16. Cianflone, K.M., Sniderman, A.D., Walsh, M.J., Vu, H.T., Gagnon, J. and Rodriguez, M.A. (1989) Purification and characterization of acylation stimulating protein. J. Biol. Chem. 264, 426-430
17. Cianflone, K., Roncari, D.A., Maslowska, M., Baldo, A., Forden, J. and Sniderman, A.D. (1994) Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33, 9489-9495
18. Cianflone, K., Xia, Z. and Chen, L.Y. (2003) Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim. Biophys. Acta. 1609, 127-143
19. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S. and Obin, M.S. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355
20. Coenen, K.R., Gruen, M.L., Chait, A. and Hasty, A.H. (2007) Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 56, 564-573
21. Conner, A.C., Simms, J., Barwell, J., Wheatley, M. and Poyner, D.R. (2007) Ligand binding and activation of the CGRP receptor. Biochem. Soc. Trans. 35, 729-732
22. Cottam, D.R., Mattar, S.G., Barinas-Mitchell, E., Eid, G., Kuller, L., Kelley, D.E. and Schauer, P.R. (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes. Surg. 14, 589-600
23. Cui, W., Paglialunga, S., Kalant, D., Lu, H., Roy, C., Laplante, M., Deshaies, Y. and Cianflone, K. (2007) Acylation stimulating protein/C5L2 neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. Am. J. Physiol Endocrinol. Metab. 293, E1482-E1491
24. DiGirolamo, M. (1991) Cellular, metabolic, and clinical consequences of adipose mass enlargement in obesity. Nutrition 7, 287-289
25. Drolet, R., Richard, C., Sniderman, A.D., Mailloux, J., Fortier, M., Huot, C., Rheaume, C. and Tchernof, A. (2007) Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int. J. Obes. (Lond). 32(2), 283-291
26. Fain, J.N. (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74, 443-477
27. Fanelli, F., Barbier, P., Zanchetta, D., de Benedetti, P.G. and Chini, B. (1999) Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol. Pharmacol. 56, 214-225
28. Funahashi, T., Nakamura, T., Shimomura, I., Maeda, K., Kuriyama, H., Takahashi, M., Arita, Y., Kihara, S. and Matsuzawa, Y. (1999) Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 38, 202-206
29. Gao, H., Neff, T.A., Guo, R.F., Speyer, C.L., Sarma, J.V., Tomlins, S., Man, Y., Riedemann, N.C., Hoesel, L.M., Younkin, E., Zetoune, F.S. and Ward, P.A. (2005) Evidence for a functional role of the second C5a receptor C5L2. FASEB J. 19, 1003-1005
30. Gavrilyuk, V., Kalinin, S., Hilbush, B.S., Middlecamp, A., McGuire, S., Pelligrino, D., Weinberg, G. and Feinstein, D.L. (2005) Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J. Neurochem. 92, 1140-1149
31. Gruijthuijsen, Y.K., Beuken, E.V., Smit, M.J., Leurs, R., Bruggeman, C.A. and Vink, C. (2004) Mutational analysis of the R33-encoded G protein-coupled receptor of rat cytomegalovirus: identification of amino acid residues critical for cellular localization and ligand-independent signalling. J. Gen. Virol. 85, 897-909
32. Guzik, T.J., Mangalat, D. and Korbut, R. (2006) Adipocytokines - novel link between inflammation and vascular function? J. Physiol Pharmacol. 57, 505-528
33. Harmon, C.M. and Abumrad, N.A. (1993) Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J. Membr. Biol. 133, 43-49
34. Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature 444, 860-867
35. Hotamisligil, G.S. and Spiegelman, B.M. (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278
36. Huber-Lang, M., Sarma, J.V., Rittirsch, D., Schreiber, H., Weiss, M., Flierl, M., Younkin, E., Schneider, M., Suger-Wiedeck, H., Gebhard, F., McClintock, S.D., Neff, T., Zetoune, F., Bruckner, U., Guo, R.F., Monk, P.N. and Ward, P.A. (2005) Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J. Immunol. 174, 1104-1110
37. Johswich, K. and Klos, A. (2007) C5L2 - an anti-inflammatory molecule or a receptor for acylation stimulating protein (C3a-desArg)? Adv. Exp. Med. Biol. 598, 159-180
38. Johswich, K., Martin, M., Thalmann, J., Rheinheimer, C., Monk, P.N. and Klos, A. (2006) Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J. Biol. Chem. 281, 39088-39095
39. Kalant, D., Cain, S.A., Maslowska, M., Sniderman, A.D., Cianflone, K. and Monk, P.N. (2003a) The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/ acylation-stimulating protein. J. Biol. Chem. 278, 11123-11129
40. Kalant, D., Maslowska, M., Scantlebury, T., Wang, H. and Cianflone, K. (2003b) Control of lipogenesis in adipose tissue and the role of acylation stimulating protein. Can. J. Diabetes 27, 154-171
41. Kalant, D., MacLaren, R., Cui, W., Samanta, R., Monk, P.N., Laporte, S.A. and Cianflone, K. (2005) C5L2 is a functional receptor for acylation- stimulating protein. J. Biol. Chem. 280, 23936-23944
42. Koerner, A., Kratzsch, J. and Kiess, W. (2005) Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come. Best. Pract. Res. Clin. Endocrinol. Metab. 19, 525-546
43. Lago, F., Dieguez, C., Gomez-Reino, J. and Gualillo, O. (2007) The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 18, 313-325
44. Lefebvre, A.M., Laville, M., Vega, N., Riou, J.P., van Gaal, L., Auwerx, J. and Vidal, H. (1998) Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47, 98-103
45. Lumeng, C.N., Bodzin, J.L. and Saltiel, A.R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184
46. Luttrell, L.M. and Lefkowitz, R.J. (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455-465
47. MacLaren, R., Kalant, D. and Cianflone, K. (2007) The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem. Cell Biol. 85, 11-21
48. Marcil, M., Vu, H., Cui, W., Dastani, Z., Engert, J.C., Gaudet, D., Castro-Cabezas, M., Sniderman, A.D., Genest, J., Jr. and Cianflone, K. (2006) Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia. Arterioscler. Thromb. Vasc. Biol. 26, 1619-1625
49. Maslowska, M., Scantlebury, T., Germinario, R. and Cianflone, K. (1997) Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J. Lipid Res. 38, 1-11
50. Maslowska, M., Vu, H., Phelis, S., Sniderman, A.D., Rhode, B.M., Blank, D. and Cianflone, K. (1999) Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur. J. Clin. Invest. 29, 679-686
51. Maslowska, M., Legakis, H., Assadi, F. and Cianflone, K. (2006) Targeting the signaling pathway of acylation stimulating protein. J. Lipid Res. 47, 643-652
52. Matarese, G., Leiter, E.H. and La Cava, A. (2007) Leptin in autoimmunity: many questions, some answers. Tissue Antigens 70, 87-95
53. Meier, U. and Gressner, A.M. (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 50, 1511-1525
54. Monk, P.N., Scola, A.M., Madala, P. and Fairlie, D.P. (2007) Function, structure and therapeutic potential of complement C5a receptors. Br. J. Pharmacol. 152, 429-448
55. Montague, C.T., Prins, J.B., Sanders, L., Zhang, J., Sewter, C.P., Digby, J., Byrne, C.D. and O'Rahilly, S. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47, 1384-1391
56. Muscari, A., Antonelli, S., Bianchi, G., Cavrini, G., Dapporto, S., Ligabue, A., Ludovico, C., Magalotti, D., Poggiopollini, G. and Zoli, M. (2007) Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population. Diabetes Care 30, 2362-2368
57. Neels, J.G. and Olefsky, J.M. (2006) Inflamed fat: what starts the fire? J. Clin. Invest. 116, 33-35
58. Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E.B., Jones, K.L., Kawamori, R., Cassis, L.A., Tschop, M.H. and Bruemmer, D. (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J. Clin. Invest. 117, 2877-2888
59. Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Eagle, A.R., Vats, D., Brombacher, F., Ferrante, A.W. and Chawla, A. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116-1120
60. Ohno, M., Hirata, T., Enomoto, M., Araki, T., Ishimaru, H. and Takahashi, T.A. (2000) A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol. Immunol. 37, 407-412C. (2005a) C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement
61. Ohyama, K., Yamano, Y., Sano, T., Nakagomi, Y., Wada, M. and Inagami, T. (2002) Role of the conserved DRY motif on G protein activation of rat angiotensin II receptor type 1A. Biochem. Biophys. Res. Commun. 292, 362-367
62. Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M.B., Brodbeck, R.M., Krause, J.E., Choe, H.R., Gerard, N.P. and Gerard, C. (2003) C5L2, a nonsignaling C5A binding protein. Biochemistry 42, 9406-9415
63. Otto, M., Hawlisch, H., Monk, P.N., Muller, M., Klos, A., Karp, C.L. and Kohl, J. (2004a) C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J. Biol. Chem. 279, 142-151
64. Otto, M., Hawlisch, H., Monk, P.N., Muller, M., Klos, A., Karp, C.L. and Kohl, J. (2004b) C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J. Biol. Chem. 279, 142-151
65. Paglialunga, S., Schrauwen, P., Roy, C., Moonen-Kornips, E., Lu, H., Hesselink, M.K., Deshaies, Y., Richard, D. and Cianflone, K. (2007) Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J. Endocrinol. 194, 293-304
66. Pausova, Z. (2006) From big fat cells to high blood pressure: a pathway to obesityassociated hypertension. Curr. Opin. Nephrol. Hypertens. 15, 173-178
67. Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters, D., Boone, T. and Collins, F. (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543
68. Pilz, S., Mangge, H., Obermayer-Pietsch, B. and Marz, W. (2007) Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. J. Endocrinol. Invest. 30, 138-144
69. Price, S.R., Olivecrona, T. and Pekala, P.H. (1986) Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor - the primary regulatory role of the hormone in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 251, 738-746
70. Rhee, M.H., Nevo, I., Levy, R. and Vogel, Z. (2000) Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor. FEBS Lett. 466, 300-304
71. Rosenkilde, M.M., Kledal, T.N. and Schwartz, T.W. (2005) High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3. Mol. Pharmacol. 68, 11-19
72. Rovati, G.E., Capra, V. and Neubig, R.R. (2007) The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol. Pharmacol. 71, 959-964
73. Saladin, R., De Vos, P., Guerre-Millo, M., Leturque, A., Girard, J., Staels, B. and Auwerx, J. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature 377, 527-529
74. Savill, J., Hogg, N. and Haslett, C. (1991) Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programmed cell death. Chest 99, 6S-7S
75. Scantlebury, T., Maslowska, M. and Cianflone, K. (1998) Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J. Biol. Chem. 273, 20903-20909
76. Scheer, A., Costa, T., Fanelli, F., de Benedetti, P.G., Mhaouty-Kodja, S., Abuin, L., Nenniger- Tosato, M. and Cotecchia, S. (2000) Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation. Mol. Pharmacol. 57, 219-231
77. Scola, A.M., Higginbottom, A., Partridge, L.J., Reid, R.C., Woodruff, T., Taylor, S.M., Fairlie, D.P. and Monk, P.N. (2007) The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. J. Biol. Chem. 282, 3664-3671
78. Seibold, A., Dagarag, M. and Birnbaumer, M. (1998) Mutations of the DRY motif that preserve beta 2-adrenoceptor coupling. Recept. Channels 5, 375-385
79. Stephens, J.M. and Pekala, P.H. (1991) Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 266, 21839-21845
80. Talle, M.A., Rao, P.E., Westberg, E., Allegar, N., Makowski, M., Mittler, R.S. and Goldstein, G. (1983) Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell Immunol. 78, 83-99
81. Tams, J.W., Knudsen, S.M. and Fahrenkrug, J. (2001) Characterization of a G protein coupling "YL" motif of the human VPAC1 receptor, equivalent to the first two amino acids in the "DRY" motif of the rhodopsin family. J. Mol. Neurosci. 17, 325-330
82. Tataranni, P.A. and Ortega, E. (2005) A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54, 917-927
83. Tchoukalova, Y.D., Sarr, M.G. and Jensen, M.D. (2004) Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am. J. Physiol. Regul. Integr. Comp Physiol. 287, R1132-R1140
84. Tilg, H. and Moschen, A.R. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783
85. Tomas, E., Tsao, T.S., Saha, A.K., Murrey, H.E., Zhang, C.C., Itani, S.I., Lodish, H.F. and Ruderman, N.B. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci.U S A 99, 16309-16313
86. Trayhurn, P. and Wood, I.S. (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92, 347-355
87. Trayhurn, P. and Wood, I.S. (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33, 1078-1081
88. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. and Hotamisligil, G.S. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614
89. Ward, P.A. (2008) Role of the complement in experimental sepsis. J. Leukoc. Biol. 83(3), 467-470
90. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante, A.W., Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808
91. Wellen, K.E. and Hotamisligil, G.S. (2003) Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785-1788
92. Wilkison, W.O., Min, H.Y., Claffey, K.P., Satterberg, B.L. and Spiegelman, B.M. (1990) Control of the adipsin gene in adipocyte differentiation. Identification of distinct nuclear factors binding to single- and double-stranded DNA. J. Biol. Chem. 265, 477-482
93. Xia, Z., Stanhope, K.L., Digitale, E., Simion, O.M., Chen, L., Havel, P. and Cianflone, K. (2004) Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. J. Biol. Chem. 279, 4051-4057
94. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A. and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin .Invest. 112, 1821-1830